您的位置: 首页 > 农业专利 > 详情页

TABLET COMPOSITION FOR ORAL ADMINISTRATION OF LENALIDOMIDE WITH IMPROVED DISINTEGRATION
专利权人:
SAMYANG BIOPHARMACEUTICALS CORPORATION;주식회사 삼양바이오팜
发明人:
PARK SANG YEOB,박상엽,LIM HYE JUNG,임혜정,LEE SA WON,이사원,SEO MIN HYO,서민효
申请号:
KR1020190043378
公开号:
KR1020190120096A
申请日:
2019.04.12
申请国别(地区):
KR
年份:
2019
代理人:
摘要:
Disclosed is an oral disintegrating tablet of lenalidomide. The present invention is to provide a lenalidomide-containing oral disintegrating tablet with improved ease of taking. The present invention is the oral disintegrating tablet in which an oral disintegration time is within 60 seconds, thereby being able to quickly disintegrate. Therefore, the oral disintegrating tablet of lenalidomide is to maiximize the convenience of taking a lenalidomide formulation mainly prescribed to elderly patients.COPYRIGHT KIPO 2020레날리도마이드의 구강붕해정을 개시한다.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充